病毒模仿逃避:致癌性KRAS突变的新作用
Raymond Chen1,2, Aobo He1,2, Daniel D De Carvalho1,2
1Department of Medical Biophysics, University of Toronto, Canada.
Molecular oncology
|November 26, 2024
概括
瘤性KRAS突变通过抑制病毒模仿阻碍了天生的免疫反应. 准KRAS会重新激活这种反应,从而提高抗癌瘤免疫疗法的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 病毒模仿,一种对内源双链RNA (dsRNA) 的天生的免疫反应,在癌症中具有治疗潜力,特别是免疫检查点抑制 (ICI).
- 瘤基因突变可以逃避瘤抑制机制,包括病毒模仿,从而导致恶性转变和耐治疗性.
研究的目的:
- 研究KRAS的一个常见的瘤基因在调节病毒模仿和对ICI治疗的反应中的作用.
- 确定KRAS突变影响dSRNA感应途径和结直肠癌免疫反应的机制.
主要方法:
- 使用了抗ICI治疗的结直肠癌模型.
- 研究了KRAS突变,AKT和STAT3信号通路以及RNA结合蛋白DDX60.0之间的相互作用.
- 评估了DDX60过度表达和KRAS向对dsRNA水平,病毒模仿和ICI疗效的影响.
主要成果:
- 在ICI耐性结直肠癌中确定KRAS作为dsRNA和病毒模拟的负调节剂.
- 证明,瘤性KRASG12D通过AKT/STAT3通路降低DDX60的调节,从而抑制病毒模仿.
- 显示恢复DDX60或准KRASG12D会增加dRNA,激活病毒模拟,并加强ICI治疗.
结论:
- 克拉斯作为病毒模拟的关键抑制剂,其致癌突变有助于癌症的免疫逃避.
- 准KRAS是一个有前途的策略,通过重新激活先天免疫反应来使"冷"瘤对ICI治疗敏感.
- 瘤基因突变可以积极破坏抗瘤免疫力,强调了解这些逃避机制对于有效治疗癌症的重要性.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Viruses with RNA Genomes
3
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
3


